CFO
CL icon

Callan Family Office’s Colgate-Palmolive CL Stock Holding History

Callan Family Office’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$932K Buy
10,930
+511
+5% +$45.5K 0.02% 581
2025
Q4 		$823K Sell
10,419
-1,283
-11% -$101K 0.02% 607
2025
Q3 		$935K Sell
11,702
-6,983
-37% -$596K 0.03% 396
2025
Q2 		$1.7M Buy
18,685
+13,848
+286% +$1.26M 0.05% 296
2025
Q1 		$453K Sell
4,837
-1,913
-28% -$171K 0.03% 346
2024
Q4 		$614K Buy
+6,750
New +$644K 0.04% 332

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Callan Family Office's CL Position: Q1 2026 in Review

Callan Family Office increased its Colgate-Palmolive (CL) stake by 4.9% in Q1 2026, buying an estimated $45.5K and bringing the position to 10,930 shares worth $932K. The position accounts for 0.02% of the portfolio, ranked #581.

Callan Family Office first reported a position in CL in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.7M in Q2 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Callan Family Office held 10,930 shares of Colgate-Palmolive worth $932K as of Q1 2026.
  • Callan Family Office bought 511 Colgate-Palmolive shares in Q1 2026, an estimated $45.5K.
  • Colgate-Palmolive made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #581 holding.
  • Callan Family Office first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 6 quarters since.
  • Callan Family Office's Colgate-Palmolive position peaked at $1.7M in Q2 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.